Aberforth Partners LLP Form 8.3 - Wincanton Plc
2024年1月20日 - 12:15AM
ＲＮＳを含む英国規制内ニュース （英語）
TIDMWIN
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON
WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of Aberforth Partners LLP, on behalf of discretionary clients.
discloser:
(b) Owner or N/A
controller of
interests and
short positions
disclosed, if
different from
1(a): The
naming of nominee
or vehicle
companies is
insufficient.
For a trust, the
trustee(s),
settlor and
beneficiaries
must be named.
(c) Name of Wincanton plc
offeror/offeree
in relation to
whose relevant
securities this
form relates:
Use a separate
form for each
offeror/offeree
(d) If an exempt N/A
fund manager
connected with an
offeror/offeree,
state this and
specify identity
of
offeror/offeree:
(e) Date position 18/01/2024
held/dealing
undertaken:
For an opening
position
disclosure, state
the latest
practicable date
prior to the
disclosure
(f) In addition YES / NO / N/A NOIf YES, specify which:
to the company in
1(c) above, is
the discloser
making
disclosures in
respect of any
other party to
the offer? If
it is a cash
offer or possible
cash offer, state
"N/A"
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class
of relevant securities of the offeror or offeree named in 1(c), copy table 2(a)
or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the
offeror or offeree to which the disclosure relates following the dealing (if
any)
Class of relevant security: Ordinary
Shares
Interests Short
positions
Number % Number %
(1) Relevant securities owned and/or 20,123,107 16.157% 0 0.0
controlled:
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including
options) and agreements to purchase/sell:
TOTAL: 20,123,107 16.157% 0 0.0
Aberforth Partners LLP does not have discretion regarding voting decisions in
respect of 4,835,896 shares included in the total disclosed above. This total
includes 4,835,896 shares held by The Wellcome Trust, who retain voting control
over their shareholding. No other client, who falls into this category, holds
more than 1% of the relevant security.
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded
options), or agreements to purchase or sell relevant securities, should be given
on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors' and
other employee options)
Class of relevant security in relation to which subscription right exists: N/A
Details, including nature of the rights concerned and relevant percentages: N/A
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities of
the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as
appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant security Purchase/sale Number of securities Price per unit
N/A- Opening Disclosure
(b) Cash-settled derivative transactions
Class of Product Nature of Number of Price per unit
relevant descriptione.g. dealinge.g. reference
security CFD opening/clos securities
ing a
long/short
position,
increasing/r
educing a
long/short
position
N/A
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, Number of Exercise Typee.g. Expiry
Option
relevant description purchasing, securities price American, date
money
security e.g. selling, to which per European
paid/
call option varying option unit etc.
received
etc. relates per
unit
N/A
(ii) Exercise
Class of Product Exercising/ Number of Exercise
relevant descriptione.g. exercised securities price per
security call option against unit
N/A
(d) Other dealings (including subscribing for new securities)
Class of Nature of dealinge.g. Details Price per unit
relevant subscription, (if applicable)
security conversion
N/A
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may
be an inducement to deal or refrain from dealing entered into by the person
making the disclosure and any party to the offer or any person acting in
concert with a party to the offer:Irrevocable commitments and letters of
intent should not be included. If there are no such agreements, arrangements
or understandings, state "none"
None
(b) Agreements, arrangements or understandings relating to options or
derivatives
Details of any agreement, arrangement or understanding, formal or informal,
between the person making the disclosure and any other person relating to:(i)
the voting rights of any relevant securities under any option; or (ii) the
voting rights or future acquisition or disposal of any relevant securities to
which any derivative is referenced:If there are no such agreements,
arrangements or understandings, state "none"
None
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 19 January 2024
Contact name: Michael Campbell, for Aberforth Partners LLP
Telephone number: 0131 220 0733
Public disclosures under Rule 8 of the Code must be made to a Regulatory
Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation
to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This information was brought to you by Cision http://news.cision.com
END
(END) Dow Jones Newswires
January 19, 2024 10:15 ET (15:15 GMT)
Wincanton (AQSE:WIN.GB)
過去 株価チャート
から 5 2024 まで 6 2024
Wincanton (AQSE:WIN.GB)
過去 株価チャート
から 6 2023 まで 6 2024
